top of page
Indication
Acute Myeloid Leukemia (AML).
All AML testing is considered urgent and given priority in the laboratory.
Targeted TAT
5 days
Please Note:
1. To expedite or rush testing, a clinical rationale must be provided; expediting or rushing testing for your patient will delay results for others. Expedited/rush testing is subject to the laboratory’s discretion in the interest of upholding equitable access for all patients.
2. Due to high volumes of inquiries and limited laboratory resources, please limit inquiries about testing status until after the targeted TAT has been exceeded.
bottom of page